LIXTE Biotechnology Holdings, Inc. ('LIXTE” or the 'Company”) (Nasdaq: LIXT and LIXTW), a clinical stage pharmaceutical ...

The two types of uterine cancer are endometrial cancer and uterine sarcoma. Each of these types has several subtypes.

(“LIXTE” or the “Company”) (Nasdaq: LIXT and LIXTW), a clinical stage pharmaceutical company, today announced that the medical journal Nature has published findings by a team of physician-scientists ...

52-year-old Sarah Mayers from Trevethin has terminal synovial sarcoma cancer and was recently given just one year to live. Sarah is currently in the process of putting in a complaint against Pontypool ...

Most ovarian cancers start in the fallopian tubes. Research and prevention efforts aim to replace tube tying with tube removal, salpingectomy.

Ovarian cysts usually aren't a cause for concern, but here's what should tip you off to see a doctor.

Ovarian cancer management is challenging due to high morbidity and mortality, often from late-stage diagnoses. Advances in tumor genomics have led to targeted therapies, improving outcomes for ...

The first trial site has been initiated in the pivotal phase 3 OVATION 3 study which will investigate IMNN-001 for newly diagnosed advanced ovarian cancer.

Dr. Elizabeth K. Lee discusses the RAINFOL-01 clinical trial evaluating treatment with Rina-S in advanced ovarian cancer.

An overlooked organ may help the ovary function New findings in mice reveal that the newly rediscovered rete ovarii may communicate with the ovary ...

This series was created for Google, the Buck Institute, Optispan and Phenome Health by Scientific American Custom Media, a division separate from the magazine’s board of editors.